We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Industry Insight

Biosciences in 2022: Bioscience Reaps Benefits From the Cloud

Technological innovations brought in as a result of COVID-19 could produce dramatic changes to how we do science. In this insight, Synthace co-founder Markus Gershater previews a cloud-first future for bioscience.
Industry Insight

How Do Spreadsheets Hold Back Pharma Innovation?

Technology Networks spoke to Jesse Harris to learn why spreadsheets can be a bottleneck for pharma research and explore how they compare to laboratory informatics tools.
Industry Insight

Sustainability and Research: Finding a Balance

Laboratories often consume three to 10 times more energy than typical non-laboratory areas of universities. We spoke to Dr Susan Simon of the Medical Research Council to learn more about their commitment to sustainability and transformation to net zero by 2040.
Industry Insight

Designing in Sustainability in Science

With a reliance on single-use plastics, significant waste and high energy usage, the carbon footprint of the biopharma industry is large. If we are to accelerate the path to net zero, it is therefore critical to ensure sustainability in science.
Industry Insight

Uncovering Real-World Patient Insights With Social Media and NLP

Historically, drug researchers have relied on methods such as focus groups and questionnaires for first-person accounts of patient-reported outcomes. Social media has emerged as a lower cost alternative that is increasingly accepted as a reputable source of information by the research community.
Industry Insight

Transformative Models for Research and Drug Discovery

Technology Networks spoke to Dr. Mark Kotter, CEO and founder of bit.bio to learn about opti-ox™ and the development, benefits and applications of ioSkeletal Myocytes.
Industry Insight

Reinventing Neuroscience Drug Discovery

Technology Networks had the pleasure of speaking with Saul Kato, the CEO of Herophilus, to learn more about how the company plans to reinvent neuro drug discovery, by combining human brain models, scaled biology and machine learning to decode brain disease.
Industry Insight

Accelerating Preclinical Biologics Development

Quick to Clinic from Thermo Fisher Scientific aims to accelerate preclinical development, enabling more rapid biologic drug development. To learn more about this solution, we spoke to Paul Jorjorian.
Industry Insight

What Is the Best Approach to Psychedelic Therapy? An Interview With Field Trip’s Ronan Levy

We spoke to co-founder and executive chairman, Ronan Levy, to find out more about Field Trip’s approach to psychedelic therapy and why 2021 has been such a significant year in psychedelics.
Industry Insight

NanoDrop 20 Years On

In this interview, Patrick Brown tells us more about the evolution of NanoDrop over the past 20 years, highlights some of the most important improvements during this time and explores what the future may hold for the technology.
Advertisement